Tiny Health Secures $33 Million Series B for Microbiome Analysis

VERA Brief

AI-generated. Grounded in the article and its cited sources.

Tiny Health has closed a $33 million Series B funding round led by B Capital. The company will use the funds to meet growing demand for its at-home microbiome testing services and to scale operations and research.

Key facts

• Tiny Health has completed a $33 million Series B funding round.
• The funding round was led by B Capital.
• The funds will be used to support growing demand for at-home microbiome testing services.
• Tiny Health aims to leverage gut data for predictive health information.
• The funding is intended to scale operations and further research into microbiome analytics.